Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

This study has been terminated.

( See termination reason in detailed description. )

Study NCT00596830 Information provided by Pfizer

First Received: January 3, 2008 Last Updated: January 14, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	February 2012
Primary Completion Date:	March 2011 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: April 22, 2011